Ingevity Corp: Board Changes and CFO Employment Agreement
Ticker: NGVT · Form: 8-K · Filed: 2024-10-03T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, executive-compensation, employment-agreement
Related Tickers: NGVT
TL;DR
Ingevity shakes up board, locks in CFO with new deal.
AI Summary
Ingevity Corporation announced on October 2, 2024, a change in its Board of Directors with the resignation of Robert J. Smith and the appointment of Dr. Michael J. McHenry as a new Class II director. Additionally, the company disclosed its entry into a new employment agreement with its Chief Financial Officer, Patrick R. Thompson, effective October 2, 2024, detailing his compensation and severance benefits.
Why It Matters
Changes in board composition and executive employment terms can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine board changes and executive employment terms, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- Robert J. Smith (person) — Resigning Director
- Dr. Michael J. McHenry (person) — Appointed Director
- Patrick R. Thompson (person) — Chief Financial Officer
- October 2, 2024 (date) — Effective date of changes
FAQ
Who has resigned from Ingevity's Board of Directors?
Robert J. Smith has resigned from Ingevity's Board of Directors.
Who has been appointed as a new Class II director?
Dr. Michael J. McHenry has been appointed as a new Class II director.
What is the effective date of the reported changes?
The earliest event reported is dated October 2, 2024.
What is the role of Patrick R. Thompson at Ingevity?
Patrick R. Thompson is the Chief Financial Officer of Ingevity.
What type of agreement has Ingevity entered into with its CFO?
Ingevity has entered into a new employment agreement with its Chief Financial Officer, Patrick R. Thompson.
Filing Stats: 1,274 words · 5 min read · ~4 pages · Grade level 13 · Accepted 2024-10-03 06:45:07
Key Financial Figures
- $0.01 — nge on which registered Common Stock ($0.01 par value) NGVT New York Stock Exch
- $3,000,000 — o will receive an annual base salary of $3,000,000 per year (which will be prorated for hi
- $1,000,000 — a fair value (as of October 2, 2024) of $1,000,000 (the "RSU Award"), which award will ves
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex99-1.htm (EX-99.1) — 18KB
- form8-k_001.jpg (GRAPHIC) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001493152-24-039288.txt ( ) — 252KB
- ngvt-20241002.xsd (EX-101.SCH) — 3KB
- ngvt-20241002_lab.xml (EX-101.LAB) — 33KB
- ngvt-20241002_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /s/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: October 3, 2024